ASYLIA THERAPEUTICS, INC.

Profile

Company Names

ASYLIA THERAPEUTICS, INC.

Addresses

3139 W HOLCOMBE BLVD, SUITE 445, HOUSTON, TX 77025

Phone Numbers

617-921-9645

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$8,193,628.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2021-02-16 
$8,193,628.00 
$16,193,628.00 
$8,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ELAN 
 
EZICKSON 
EXECUTIVE OFFICER, DIRECTOR
AVEO PHARMACEUTICALS INC   |  MARINUS PHARMACEUTICALS INC   |  ASYLIA THERAPEUTICS, INC.   |  MARINUS PHARMACEUTICALS, INC.   |  CARMINE THERAPEUTICS, INC.
JENO 
 
GYURIS 
EXECUTIVE OFFICER, DIRECTOR
AVEO PHARMACEUTICALS INC   |  ASYLIA THERAPEUTICS, INC.
JOSEPH 
 
KEKST 
DIRECTOR
IMMUNEERING CORP   |  ASYLIA THERAPEUTICS, INC.   |  VIDAFUEL, INC.   |  APIS POINT ENERGY INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-03-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#